Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
LENSAR, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
05/15/2023 8-K Quarterly results
Docs: "LENSAR Reports First Quarter 2023 Results and Provides Business Update Increased ALLY® Adaptive Cataract Treatment System installed base to 19 systems with a backlog of additional 13 systems as of May 12, 2023 U.S. procedure volumes increased 13% over first quarter 2022; Procedure volumes increased >20% year-over-year at sites that have upgraded from LENSAR Laser System to ALLY Significantly strengthened balance sheet through $20 million private placement ORLANDO, Fla. – LENSAR, Inc. , a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended March 31, 2023 and provided an update on key operational initiatives. “I am thrilled with the growing momentum ALLY is ex..."
03/16/2023 8-K Quarterly results
Docs: "LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update Installed ten ALLY® Adaptive Cataract Treatment Systems in 2022 with contracts for six additional ALLY Systems executed in December 2022; Installations expected in first half 2023 Positive surgeon feedback reinforces next generation speed, efficiency and economic benefits of ALLY ORLANDO, Fla. – LENSAR, Inc. , a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter and full year ended December 31, 2022 and provided an update on key operational initiatives. “The reception to our next generation ALLY System supports our confidence in this new technology and its potential to change th..."
11/09/2022 8-K Quarterly results
Docs: "LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update Company Launches ALLY™ Adaptive Cataract Treatment System Third Quarter U.S. Procedure Volume Increases 9% over Q3 2021 ORLANDO, Fla. – LENSAR, Inc. , a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended September 30, 2022 and provided a business update. “The third quarter was highlighted by the successful U.S. launch of the ALLY System during the week of August 15th, a pivotal corporate milestone, and the next important step in continuing the transition to our next generation system. We have installed multiple ALLY Systems in select sites with surgeons performing cases with th..."
08/08/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
03/03/2022 8-K Quarterly results
11/08/2021 8-K Quarterly results
Docs: "LENSAR, Inc."
08/05/2021 8-K Quarterly results
Docs: "LENSAR Reports Second Quarter 2021 Financial Results and Provides Business Update Second Quarter and First Half 2021 Procedure Volumes Increase 70% and 42% over 2020 Levels"
05/05/2021 8-K Quarterly results
03/10/2021 8-K Quarterly results
11/09/2020 8-K Quarterly results
Docs: "LENSAR Reports Third Quarter 2020 Financial Results and Provides Business Update"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy